Business context and reporting period
This is CM Seven Star Acquisition Corporation’s Form 10-K for the fiscal year ended December 31, 2017—not a filing identified in its text as Kaixin Holdings. The company was a Cayman Islands blank-check company formed to pursue a business combination, with no target selected or operating business at year-end. Its operating activity was limited to seeking and evaluating acquisition candidates.
The IPO closed in October 2017. The company sold 20,636,293 public units in total, including a partial over-allotment, and completed related private placements with its sponsor. The filing reports 26,323,092 ordinary shares outstanding as of April 2018.
Financial results and position
| Metric | FY 2017 / Dec. 31, 2017 |
|---|---|
| Revenue | None; the company had no operating revenue. |
| Formation and operating costs | $85,806 |
| Trust-account interest income | $423,056 |
| Net income | $337,250, or $0.06 per basic and diluted share |
| Cash outside trust | $165,405 |
| Cash held in trust | $206,785,848 |
| Total assets | $207,010,349 |
| Current liabilities | $19,859, including $4,289 due to related parties |
| Long-term debt | None reported at year-end |
| Cash flow from operations | $(124,905) |
Trust funds were generally unavailable for operating expenses before a business combination. The company reported no off-balance-sheet arrangements or long-term contractual obligations. No operating margin is meaningful because it had no revenue.
Material changes versus the prior comparable period
Compared with the November 28–December 31, 2016 inception period, when the company recorded a $9,502 net loss and had $75,000 in assets, 2017 included the IPO, sponsor private placements, and placement of $206.4 million of proceeds into trust. The 2017 net profit resulted from trust interest exceeding formation and operating costs, not from operating activity.
Outlook, risks, contingencies, and unusual items
- The company had 15 months from the October 2017 IPO to complete a business combination, with a possible three-month extension if insiders deposited $2,063,629 into trust. Failure to complete a transaction would trigger liquidation; public shareholders would receive a pro rata trust distribution, subject to creditor claims, while warrants and rights would expire worthless.
- Management stated that $165,405 of outside-trust cash, together with sponsor financing available after the reporting date, was expected to fund operations for at least 12 months. The notes nevertheless state that uncertainty about raising additional capital raised substantial doubt about the company’s ability to continue as a going concern.
- On April 9, 2018, the sponsor agreed to provide a $500,000 non-interest-bearing, non-convertible loan, repayable after a business combination and forgivable if no combination is completed. This is a subsequent event, not year-end debt.
- Key risks include failure to find or complete a suitable transaction, limited cash outside trust, redemptions reducing transaction funds, competition, possible need for further financing, creditor claims against trust assets, and conflicts of interest arising from management’s other affiliations.
- A 3.5% fee on IPO gross proceeds is payable to EarlyBirdCapital upon consummation of a business combination. The underwriter also received an option to purchase up to 900,000 units; the filing records its estimated fair value of $3,271,400 as an offering cost charged to equity.
- The auditor issued an unqualified opinion on the financial statements. Management reported effective disclosure controls, but the company did not include a management assessment or auditor attestation of internal control over financial reporting.
Most important facts to verify
- Confirm the filing entity: the supplied company label says Kaixin Holdings, while the 10-K identifies CM Seven Star Acquisition Corporation.
- Review the audited statements and notes for trust balances, redemption classification, expenses, and the stated going-concern uncertainty.
- Verify the applicable business-combination deadline, extension funding status, and any subsequent transaction or financing developments.
- Assess potential redemptions, dilution from warrants, rights and the underwriter’s unit option, and the 3.5% transaction fee.
- Examine related-party arrangements, management conflicts, and the protections and limitations relating to claims against trust funds.